norethindrone acetate has been researched along with Diabetes Mellitus, Type 2 in 6 studies
norethisterone acetate : A 3-oxo Delta(4)-steroid that is norethisterone in which the hydroxy group has been converted to its acetate ester.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Type 2 diabetes and metabolic syndrome are major cardiovascular risk factors in postmenopausal women, but the role of vasoconstrictive endothelin-1 (ET-1) in these conditions is not known." | 5.09 | Plasma endothelin in postmenopausal women with type 2 diabetes mellitus and metabolic syndrome: a comparison of oral combined and transdermal oestrogen-only replacement therapy. ( Puolakka, J; Saltevo, J; Ylikorkala, O, 2000) |
| "Thirty-one postmenopausal women with type 2 diabetes, glycosylated haemoglobin (HbA1c) of 6% or more and sex hormone-binding globulin (SHBG) values of 60 nmol/L or less were included." | 2.72 | The effect of continuous combined HRT on glucose homeostasis and plasma lipids. A placebo-controlled study in postmenopausal women with type 2 diabetes. ( Andersson, B; Glassell, M; Mattsson, LA; Thunell, L, 2006) |
| "Some menopausal women with type 1 diabetes are treated with hormone replacement therapy (HRT) but the effects of this treatment have, to date, not been established." | 2.49 | Hormone replacement therapy for women with type 1 diabetes mellitus. ( Adamson, KA; Chisholm, J; Kilbride, L; Mackay, L, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mackay, L | 1 |
| Kilbride, L | 1 |
| Adamson, KA | 1 |
| Chisholm, J | 1 |
| Scott, AR | 1 |
| Dhindsa, P | 1 |
| Forsyth, J | 1 |
| Mansell, P | 1 |
| Thunell, L | 1 |
| Andersson, B | 1 |
| Glassell, M | 1 |
| Mattsson, LA | 1 |
| Owens, D | 1 |
| Collins, PB | 1 |
| Johnson, A | 1 |
| Tomkin, GH | 1 |
| Cornu, C | 1 |
| Mercier, C | 1 |
| Ffrench, P | 1 |
| Bully, C | 1 |
| Pugeat, M | 1 |
| Cousin, P | 1 |
| Riou, JP | 1 |
| Bajart, L | 1 |
| Orgiazzi, J | 1 |
| Pommet-Nicot, C | 1 |
| Darsy, P | 1 |
| Boissel, JP | 1 |
| Berthezène, F | 1 |
| Saltevo, J | 1 |
| Puolakka, J | 1 |
| Ylikorkala, O | 1 |
1 review available for norethindrone acetate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Hormone replacement therapy for women with type 1 diabetes mellitus.
Topics: Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Estradiol; Estrogen Replacement | 2013 |
5 trials available for norethindrone acetate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Effect of hormone replacement therapy on cardiovascular risk factors in postmenopausal women with diabetes.
Topics: Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabe | 2004 |
The effect of continuous combined HRT on glucose homeostasis and plasma lipids. A placebo-controlled study in postmenopausal women with type 2 diabetes.
Topics: Aged; Blood Glucose; Body Mass Index; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Me | 2006 |
Lipoproteins and low-dose estradiol replacement therapy in post-menopausal Type 2 diabetic patients: the effect of addition of norethisterone acetate.
Topics: Aged; Carrier Proteins; Cholesterol; Cholesterol Ester Transfer Proteins; Diabetes Mellitus, Type 2; | 2000 |
Postmenopause hormone treatment in women with NIDDM or impaired glucose tolerance: the MEDIA randomized clinical trial.
Topics: Biomarkers; Chlormadinone Acetate; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Com | 2000 |
Plasma endothelin in postmenopausal women with type 2 diabetes mellitus and metabolic syndrome: a comparison of oral combined and transdermal oestrogen-only replacement therapy.
Topics: Administration, Cutaneous; Administration, Oral; Biomarkers; Body Constitution; Body Mass Index; Cho | 2000 |